Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 16 days ago
Share
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
287 patients around the world
Available in
Spain, United States, Argentina
Amgen
3
Research sites
287
Patients around the world
This study is for people with
Leukemia
Acute lymphoblastic leukemia
Requirements for the patient
To 100 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hematológica Alta Especialidad - Huixquilucan de Degollado
Recruiting
View site
Hospital Angeles Lomas consultorio 830. Vialidad de la Barranca s/n, 52787 Huixquilucan de Degollado
Hematológica Alta Especialidad - Huixquilucan de Degollado
Recruiting
View site
Hospital Angeles Lomas consultorio 830. Vialidad de la Barranca s/n, 52787 Huixquilucan de Degollado
COI Centro Oncológico Internacional S.A.P.I
Recruiting
View site
Periferico Sur 5246, Coyoacán, Ciudad de México
COI Centro Oncológico Internacional S.A.P.I
Recruiting
View site
Periferico Sur 5246, Coyoacán, Ciudad de México
BRCR Global - Ciudad de Mexico
Recruiting
View site
Calle Sur 132 108, Las Américas, Álvaro Obregón, 01120 Ciudad de México, CDMX, Mexico
BRCR Global - Ciudad de Mexico
Recruiting
View site
Calle Sur 132 108, Las Américas, Álvaro Obregón, 01120 Ciudad de México, CDMX, Mexico
See details
Contact us
Contact us
Sponsor
Amgen
Conditions
Acute lymphoblastic leukemia
Requirements
To 100 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT04994717
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent